摘要

We report the identification of a new human tumor necrosis factor-alpha (TNF-alpha) specific peptide selected by competitive panning of a phage library. Competitive elution of phages was obtained using the monoclonal antibody adalimumab, which neutralizes pro- inflammatory processes caused by over-production of TNF-alpha in vivo, and is used to treat severe symptoms of rheumatoid arthritis. The selected peptide was synthesized in monomeric and branched form and analyzed for binding to TNF-alpha and competition with adalimumab and TNF-alpha receptors. Results of competition with TNF-alpha receptors in surface plasmon resonance and melanoma cells expressing both TNF receptors make the peptide a candidate compound for the development of a novel anti-TNF-alpha drug.

  • 出版日期2014-6